Even though there is evidence suggesting that the type I IFN pathway is involved in tumor surveillance [28,29], to date, IFN blockade has not been associated with CML, and there have been no reports of spontaneous tumor formation in IFNAR-deficient mice. This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.